Thank you Brittany Cordeiro for the A-mazing job making this meeting a reality for NCI Neuro-Oncology Branch #NCIconnect !

A simple standardized assessment often as part of a NP/MD clinical exam-but can it distinguish patients who have issues or early changes? This and the Healthmeasures perceived cognitive issues are teaching us a lot.1 of the 1st studies exploring use in telehealth #btsm

Wonderful presentation by NIH Office of Intramural Training & Education postbac Jaime Garcia and discussion of the importance of work to support coping strategies by these stellar scientistd! #BTSM

REGISTER: The Early Investigator Advancement Program (EIAP) helps to facilitate the advancement of scientists from diverse backgrounds to become independent investigators. Join us for an EIAP Pre-Application Webinar on October 11 at 3:00 pm ET. cancer.gov/about-nci/orga… @ncicrchd

The effectiveness of antiepileptic drug treatment in glioma patients: lamotrigine versus lacosamide NS Tumor Section #BTSM #epilepsy #surgery link.springer.com/article/10.100…

Protecting myself, my family, my coworkers, and our patients along with Dr Fauci! NCI Center for Cancer Research NCI Neuro-Oncology Branch: #NIHFoilTheFlue2022 #NoTimeForFlu   #MaskUp #LatherUp #SleeveUp

Most important folks to advise #btsm #wisdom #patientvoice

Are you someone committed to understanding barriers to clinical trial participation and ensuring equitable access for all? Consider applying to this position NCI Center for Cancer Research - creative, collaborative scientists with innovative ideas should apply! #Diversity #Equity #inclusion

Two new studies have uncovered a vulnerability in gliomas that may render these brain tumors susceptible to the same treatment: a drug called BAY 2402234. Cancer metabolism expert Mioara Larion, Ph.D talked to National Cancer Institute about these findings and their implications: go.cancer.gov/kSOmdGy

Please email [email protected] for a free copy

What an incredible honor to be able to share the work at NCI Center for Cancer Research All Hands that we do & to have the opportunity to do this type of work in CCR through #CCR -OPCORe . Thank you Tom Misteli, Ph.D. & @gulleyj1 for your leadership & support of this science.

I am excited to welcome new Dr. Monica M. Bertagnolli Dr. Monica M. Bertagnolli to National Cancer Institute. I look forward to working together to create the cancer medicines of tomorrow. Thanks to our CCR colleague Dr. Doug Lowy for his leadership and guidance over the past few months as Acting Director.

Ependymoma survivor, Savannah, shares her story of being a young adult living with cancer. 'I want people to know that we are trying our best to live our lives. And that we need non-judgemental support for others around us.'

Read more: bit.ly/3RrIZMN

Dr. Monica M. Bertagnolli National Cancer Institute On behalf of the American Brain Tumor Association, congratulations to you as you begin your leadership role with the NCI. We look forward to working with you and of continuing to work with many of your colleagues, including Drs Gilbert and Armstrong of NCI-CONNECT. American Brain Tumor Association

Congratulations #TitoMendoza on this important work in #Immunotherapy & #rarecancers - so grateful to have you as a partner in NCI Center for Cancer Research Office of Patient-Centered Outcomes (OPCORe) & collaboration in our Cancer Moonshot 2020 NCI Neuro-Oncology Branch #NCIconnect program!

Happiness is….When your daughter texts you to tell you that a cool support project for young adult cancer survivors that she was involved in was just accepted for publication! Congrats Grace Armstrong, M.A., LPC and to the researchers and teams you worked with! #Cancersurvivorship

Exercise break from reviewing grants- and then your geriatric dog is better at yoga then you…..

So goad you are there Macy Stockdill, PhD, RN ! Good luck and cant wait to learn from you on your return to NCI Neuro-Oncology Branch #btsm #caregiving

#ICYMI : We are launching the #CancerMoonshot Scholars Program and have put out the first FOA. Applications are due Nov. 8.

We encourage you to share the announcement with your colleagues and professional networks and, if eligible, to apply.